Results 81 to 90 of about 8,269 (200)

Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions

open access: yes, 2019
Chronic myelomonocytic leukemia (CMML) is a myeloid neoplasm characterized by dysplasia, abnormal production and accumulation of monocytic cells and an elevated risk to transform into acute leukemia. Over the past two decades, our knowledge about the pathogenesis and molecular mechanisms in CMML has increased substantially.
Valent, Peter   +29 more
openaire   +1 more source

Safety, Pharmacokinetics, and Efficacy Study of Porcine and Rabbit Antithymocyte Globulin in the Treatment of Patients With Severe Aplastic Anemia: A Multicenter, Prospective, Randomized, Open‐Label Clinical Trial

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This prospective trial compared porcine‐ATG and rabbit‐ATG for severe aplastic anemia. Both agents peaked on Day 5, with faster clearance for rabbit‐ATG. Porcine‐ATG induced an early stable neutrophil rise, whereas rabbit‐ATG caused an initial neutrophil drop.
Yawen Zhang   +4 more
wiley   +1 more source

Comparison of venetoclax and azacitidine versus a cytarabine‐based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real‐world study of the DATAML‐IPC‐AURAML consortium

open access: yesBritish Journal of Haematology, Volume 209, Issue 5, Page 2160-2167, November 2026.
Summary Complete remission (CR) rates for patients with acute myeloid leukaemia (AML) treated with intensive chemotherapy (IC) have increasingly improved. Yet, relapse remains a concern with a dismal prognosis. In this report, results are presented of a retrospective analysis comparing salvage therapy based on intermediate (I) or high (H)‐dose ...
Pierre‐Yves Dumas   +22 more
wiley   +1 more source

The lymphocyte function of allogeneic peripheral blood stem cell grafts is associated with relapse and cytomegalovirus reactivation

open access: yesTransfusion, Volume 66, Issue 11, Page 2302-2312, November 2026.
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström   +8 more
wiley   +1 more source

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee [PDF]

open access: yes
Chronic myelomonocytic leukemia (CMML) is a heterogeneous disease presenting with either myeloproliferative or myelodysplastic features. Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only potentially curative option, but the ...
Santini, Valeria   +23 more
core   +1 more source

A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML [PDF]

open access: yes, 2016
Chronic myelomonocytic leukaemia (CMML) and juvenile myelomonocytic leukaemia (JMML) are two disease entities that come under the myelodysplastic/myeloproliferative neoplasms category. Each of the two conditions has its own diagnostic criteria.
Mohmmed U. Manzoor   +3 more
core   +1 more source

Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CMML patients.

open access: yes, 2017
Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CMML patients.
Xiao-Hui Dong (3716569)   +7 more
core   +1 more source

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies [PDF]

open access: yes, 2015
Since its reclassification as a distinct disease entity, clinical research efforts have attempted to establish baseline characteristics and prognostic scoring systems for chronic myelomonocytic leukemia (CMML).
R. Itzykson   +20 more
core   +1 more source

Transformation of CMML to AML presenting with acute kidney injury.

open access: yes, 2020
Characterized by bone marrow dysplasia and peripheral blood monocytosis, chronic myelomonocytic leukemia (CMML) is one of the most aggressive chronic leukemias and has a propensity for progression to acute myeloid leukemia (AML).
Garrahy, Ian   +3 more
core   +2 more sources

Forest plot of the HR and 95% CI for OS in CMML patients.

open access: yes, 2017
Forest plot of the HR and 95% CI for OS in CMML patients.
Xiao-Hui Dong (3716569)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy